Introduction

Overview of PMCT for Pathologist Triage

Overview of PMCT for Pathologist Triage

-

This webinar originally occurred on April 20, 2021
Duration: 1 hour

Overview

In the second webinar, participants were introduced to the use of PMCT as a triage tool in a busy forensic pathology practice. Participants first learned about the history of the use of PMCT at the New Mexico Office of the Medical Investigator (OMI) and the existing research and literature on the efficacy of PMCT in the medical examiner setting.  

PMCT has become a vital tool in the triage of cases at the OMI.  Participants were introduced to the daily triage of cases and how PMCT is utilized by the pathologists to determine whether or not individual cases need to receive a full autopsy, a partial autopsy, or an external examination.
 This was done through a case-based discussion with pertinent histories and CT findings. The use of ancillary testing, including urine drug screening, confirmatory toxicology testing, and nasopharyngeal swabs were reviewed in the context of PMCT. 

Participants reviewed how OMI has created updated standard operating procedures to guide pathologist triage with PMCT and the importance of the creation of clear guidelines
for the incorporation of PMCT into practice. In addition, challenges and limitations of the use of PMCT for case triage were identified.


Detailed Learning Objectives

  1. Participants will be familiar with the current research and literature on the use of PMCT in forensic pathology.
  2. Participants will have a basic understanding of how PMCT can be utilized in the daily triaging of cases for examination and ancillary testing.
  3. Participants will appreciate the need to develop standard operating guidelines for the use of PMCT by pathologists in the office.

Presenter

  • Clarissa S. Krinsky, MD, CFP | Medical Examiner at the New Mexico Office of the Medical Investigator

Funding for this Forensic Technology Center of Excellence webinar has been provided by the National Institute of Justice, Office of Justice Programs, U.S. Department of Justice.

The opinions, findings, and conclusions or recommendations expressed in this webinar are those of the presenter(s) and do not necessarily reflect those of the U.S. Department of Justice.

Contact us at ForensicCOE@rti.org with any questions and subscribe to our newsletter for notifications.


Related Content

White Paper – Information Sharing Between Medicolegal Death Investigators and Toxicology Testing Services

Date December 2023 Overview The National Institute of Justice (NIJ)-in partnership with its Forensic Technology Center of Excellence (FTCOE) at RTI International and the National Center for Health Statistics, Centers for Disease Control and Prevention (CDC)-convened a virtual Medicolegal Death…

White Paper – Electronic Death Registry in Medicolegal Death Investigation

Date December 2023 Overview The National Institute of Justice (NIJ)-in partnership with its Forensic Technology Center of Excellence (FTCOE) at RTI International and the National Center for Health Statistics, Centers for Disease Control and Prevention (CDC)-convened a virtual Medicolegal Death…

What FSSP Leaders Should Know about Artificial Intelligence and its Application to Forensic Science In-Brief

Date December 2023 Overview Artificial intelligence (AI), which leverages computers to perform tasks that enhance decision-making, problem-solving capabilities, and technology-driven innovativeness,” is a rapidly growing area of interest for both industry and the federal research and development (R&D) community.1 For forensic science service…